BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33140131)

  • 21. Electronic brachytherapy for non-melanoma skin cancer in Asians: Experience from a Taiwan medical center.
    Tang TY; Tang JY; Chu-Sung Hu S; Chiao-Li Ke K; Cheng ST
    J Formos Med Assoc; 2022 Nov; 121(11):2317-2323. PubMed ID: 35570050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma.
    Sedda AF; Rossi G; Cipriani C; Carrozzo AM; Donati P
    Clin Exp Dermatol; 2008 Nov; 33(6):745-9. PubMed ID: 18681873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients.
    Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose-rate brachytherapy for non-melanoma skin cancer using tailored custom moulds - a single-centre experience.
    Laliscia C; Fuentes T; Coccia N; Mattioni R; Perrone F; Paiar F
    Contemp Oncol (Pozn); 2021; 25(1):12-16. PubMed ID: 33911976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
    Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
    Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High dose rate brachytherapy with customized applicators for malignant facial skin lesions.
    Jumeau R; Renard-Oldrini S; Courrech F; Buchheit I; Oldrini G; Vogin G; Peiffert D
    Cancer Radiother; 2016 Jul; 20(5):341-6. PubMed ID: 27321412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-melanoma skin cancer treated with high-dose-rate brachytherapy and Valencia applicator in elderly patients: a retrospective case series.
    Delishaj D; Laliscia C; Manfredi B; Ursino S; Pasqualetti F; Lombardo E; Perrone F; Morganti R; Paiar F; Fabrini MG
    J Contemp Brachytherapy; 2015 Dec; 7(6):437-44. PubMed ID: 26816500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction to: High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results.
    Castellucci P; Savoia F; Farina A; Lima GM; Patrizi A; Baraldi C; Zagni F; Vichi S; Pettinato C; Morganti AG; Strigari L; Fanti S
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1706. PubMed ID: 33871669
    [No Abstract]   [Full Text] [Related]  

  • 31. [Endovascular brachytherapy (EVBT) with Rhenium-188 for restenosis prophylaxis after angioplasty of infrainguinal lesions: early experience].
    Leissner GG; Wengenmair H; Sciuk J; Woelfle KD; Winterstein A; Weinrich K; Bohndorf K; Wohlgemuth WA
    Rofo; 2011 Aug; 183(8):735-42. PubMed ID: 21800265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer.
    Lancellotta V; Kovács G; Tagliaferri L; Perrucci E; Rembielak A; Stingeni L; Tramontana M; Hansel K; Colloca G; Saldi S; Valentini V; Aristei C
    J Geriatr Oncol; 2019 May; 10(3):514-517. PubMed ID: 30314955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
    Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
    Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face.
    Gogineni E; Cai H; Carillo D; Rana Z; Bloom B; Potters L; Gaballa H; Ghaly M
    J Contemp Brachytherapy; 2021 Feb; 13(1):51-58. PubMed ID: 34025737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
    Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
    Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation therapy for Bowen's disease of the skin.
    Lukas VanderSpek LA; Pond GR; Wells W; Tsang RW
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):505-10. PubMed ID: 16168842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.
    Bhatnagar A
    Brachytherapy; 2013; 12(2):134-40. PubMed ID: 23312675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.